Flow Diversion after Aneurysmal Subarachnoid Hemorrhage

Sabareesh K. Natarajan; Hussain Shallwani; Vernard S. Fennell; Jeffrey S. Beecher; Hakeem J. Shakir; Jason M. Davies; Kenneth V. Snyder; Adnan H. Siddiqui; Elad I. Levy

doi:10.1016/j.nec.2017.02.011

Flow Diversion after Aneurysmal Subarachnoid Hemorrhage

Sabareesh K. Natarajan
, Hussain Shallwani
, Vernard S. Fennell
, Jeffrey S. Beecher
, Hakeem J. Shakir
, Jason M. Davies
, Kenneth V. Snyder
, Adnan H. Siddiqui
, Elad I. Levy

Neurosurgery

SUNY Buffalo
Women and Children's Hospital of Buffalo
Jacobs Institute

Research output: Contribution to journal › Review article › peer-review

16 Scopus citations

Abstract

Flow diversion after aneurysmal subarachnoid hemorrhage (SAH) is the last treatment option for aneurysm occlusion when other methods of aneurysm treatment cannot be used because of the need for dual antiplatelet therapy. The authors’ general protocol for treatment selection after aneurysmal SAH is provided to share with readers our approach to securing the aneurysm before embarking flow diversion for primary treatment or delayed adjunctive treatment to primary coiling. The authors’ experience with flow diversion after aneurysmal SAH, review of pertinent literature, and the future of flow diversion after aneurysmal SAH are discussed.

Original language	English
Pages (from-to)	375-388
Number of pages	14
Journal	Neurosurgery Clinics of North America
Volume	28
Issue number	3
DOIs	https://doi.org/10.1016/j.nec.2017.02.011
State	Published - Jul 2017

Keywords

Cerebral aneurysm
Flow diversion
Pipeline Embolization Device
Subarachnoid hemorrhage

Access to Document

10.1016/j.nec.2017.02.011

Cite this

@article{18021ba6c19d43fb88d207dd292186c6,

title = "Flow Diversion after Aneurysmal Subarachnoid Hemorrhage",

abstract = "Flow diversion after aneurysmal subarachnoid hemorrhage (SAH) is the last treatment option for aneurysm occlusion when other methods of aneurysm treatment cannot be used because of the need for dual antiplatelet therapy. The authors{\textquoteright} general protocol for treatment selection after aneurysmal SAH is provided to share with readers our approach to securing the aneurysm before embarking flow diversion for primary treatment or delayed adjunctive treatment to primary coiling. The authors{\textquoteright} experience with flow diversion after aneurysmal SAH, review of pertinent literature, and the future of flow diversion after aneurysmal SAH are discussed.",

keywords = "Cerebral aneurysm, Flow diversion, Pipeline Embolization Device, Subarachnoid hemorrhage",

author = "Natarajan, \{Sabareesh K.\} and Hussain Shallwani and Fennell, \{Vernard S.\} and Beecher, \{Jeffrey S.\} and Shakir, \{Hakeem J.\} and Davies, \{Jason M.\} and Snyder, \{Kenneth V.\} and Siddiqui, \{Adnan H.\} and Levy, \{Elad I.\}",

note = "Publisher Copyright: {\textcopyright} 2017 Elsevier Inc.",

year = "2017",

month = jul,

doi = "10.1016/j.nec.2017.02.011",

language = "English",

volume = "28",

pages = "375--388",

journal = "Neurosurgery Clinics of North America",

issn = "1042-3680",

publisher = "W.B. Saunders",

number = "3",

}

TY - JOUR

T1 - Flow Diversion after Aneurysmal Subarachnoid Hemorrhage

AU - Natarajan, Sabareesh K.

AU - Shallwani, Hussain

AU - Fennell, Vernard S.

AU - Beecher, Jeffrey S.

AU - Shakir, Hakeem J.

AU - Davies, Jason M.

AU - Snyder, Kenneth V.

AU - Siddiqui, Adnan H.

AU - Levy, Elad I.

PY - 2017/7

Y1 - 2017/7

N2 - Flow diversion after aneurysmal subarachnoid hemorrhage (SAH) is the last treatment option for aneurysm occlusion when other methods of aneurysm treatment cannot be used because of the need for dual antiplatelet therapy. The authors’ general protocol for treatment selection after aneurysmal SAH is provided to share with readers our approach to securing the aneurysm before embarking flow diversion for primary treatment or delayed adjunctive treatment to primary coiling. The authors’ experience with flow diversion after aneurysmal SAH, review of pertinent literature, and the future of flow diversion after aneurysmal SAH are discussed.

AB - Flow diversion after aneurysmal subarachnoid hemorrhage (SAH) is the last treatment option for aneurysm occlusion when other methods of aneurysm treatment cannot be used because of the need for dual antiplatelet therapy. The authors’ general protocol for treatment selection after aneurysmal SAH is provided to share with readers our approach to securing the aneurysm before embarking flow diversion for primary treatment or delayed adjunctive treatment to primary coiling. The authors’ experience with flow diversion after aneurysmal SAH, review of pertinent literature, and the future of flow diversion after aneurysmal SAH are discussed.

KW - Cerebral aneurysm

KW - Flow diversion

KW - Pipeline Embolization Device

KW - Subarachnoid hemorrhage

UR - https://www.scopus.com/pages/publications/85020871859

U2 - 10.1016/j.nec.2017.02.011

DO - 10.1016/j.nec.2017.02.011

M3 - Review article

C2 - 28600012

AN - SCOPUS:85020871859

SN - 1042-3680

VL - 28

SP - 375

EP - 388

JO - Neurosurgery Clinics of North America

JF - Neurosurgery Clinics of North America

IS - 3

ER -

Flow Diversion after Aneurysmal Subarachnoid Hemorrhage

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this